Life Science News

RSS

New CAR T cell therapy approach minimizes severe side effects

In recent years, cancer researchers have hailed the arrival of chimeric antigen receptor T cell (CAR T) therapy, which has delivered promising results, transforming the fight against various forms of cancer. The process involves modifying patients' T-cells to target cancer cells, resulting in remarkable success rates for previously intractable forms of cancer.

19 Sep 2023

New research offers insight about the reason mitochondrial DNA is maternally inherited

New research provides insight about the bedrock scientific principle that mitochondrial DNA - the distinct genetic code embedded in the organelle that serves as the powerplant of every cell in the body - is exclusively passed down by the mother.

19 Sep 2023

Meridian Bioscience announces FDA clearance for innovative Curian® Shiga Toxin Assay

Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials.

From Meridian Bioscience, Inc. 18 Sep 2023

Meridian Bioscience continues expansion of H. pylori diagnostic testing solutions with FDA clearance of premier HpSA flex

Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials.

From Meridian Bioscience, Inc. 18 Sep 2023

Single-cell screening of cerebral organoids to identify developmental defects in autism

Researchers develop CRISPR-human organoids-single-cell RNA sequencing system to identify developmental brain defects in autism.

18 Sep 2023

MGI partners with National Cancer Centre Singapore to undergo comprehensive genomic profiling of Asian-Prevalent cancers

MGI Tech Singapore Pte, Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, recently entered a research partnership with National Cancer Centre Singapore ("NCCS") to facilitate comprehensive, multi-dimensional genomic profiling of Asian-prevalent cancers using MGI's core DNBSEQ™ technology.

From MGI 18 Sep 2023

MGI and Bio-Medical Science sign MOU to deliver cutting-edge sequencing platforms and reagents to South Korea

MGI, a company committed to building core tools and technology to lead life science, today announced MOU with Bio-Medical Science Co., Ltd. ("BMS") to expand genomics solutions in South Korea by leveraging MGI's cutting-edge technology.

From MGI 18 Sep 2023

MGI's innovative technologies Is enabling sequencing of first plant species in the African BioGenome project

MGI, a company committed to building core tools and technology to lead life science, is delighted to support The African BioGenome Project (AfricaBP), launched in 2021, in sequencing of the project's first plant species based on MGI's DNBSEQ-G400* versatile benchtop sequencer and single-tube long fragment read (stLFR) technology.

From MGI 18 Sep 2023

MGI introduces new chapter in smart laboratory management with official opening of αLab in HKSTP

MGI, a company committed to building core tools and technology to lead life science, today announced the official opening of αLab in the Hong Kong Science & Technology Parks ("HKSTP"), the city's largest R&D base and one of the most important incubators.

From MGI 18 Sep 2023

Turning fish waste into cancer fighters: How abalone viscera peptides could be the next big thing in medicine

Researchers explore the potential of bioactive peptides from abalone fish viscera for their antimicrobial and anticancer properties. The study finds promising activity against various bacterial and fungal strains, as well as cytotoxic effects on prostate cancer cells.

17 Sep 2023

How well do current vaccines hold up against new SARS-CoV-2 variants BA.2.86 and FLip?

The study explores the efficacy of three-dose monovalent or bivalent vaccinations in neutralizing newly emerged SARS-CoV-2 variants BA.2.86 and FLip. While BA.2.86 showed lower immune evasion abilities compared to recent XBB variants, it was less effectively neutralized by the monoclonal antibody S309, raising questions about vaccine efficacy against evolving strains.

17 Sep 2023

BU researchers receive NIH grant to identify genetic factors for Alzheimer's disease

The National Institutes of Health/National Institute on Aging recently awarded a $13.7 million grant to a project led by Boston University Chobanian & Avedisian School of Medicine principal investigators Lindsay Farrer, PhD, chief of biomedical genetics and distinguished professor of genetics, and Richard Sherva, PhD, assistant professor of medicine in biomedical genetics, for research using whole genome sequencing and other approaches to identify genetic factors for Alzheimer disease (AD) in Jews currently living in Israel who trace their ancestors to southern Spain and locations in the Middle East and North Africa (MENA) and Arab citizens of Israel.

15 Sep 2023

NICER: A safer alternative to CRISPR/Cas9 for gene editing

The gene editing technique CRISPR/Cas9 has allowed researchers to make precise and impactful changes to an organism's DNA to fix mutations that cause genetic disease.

15 Sep 2023

Ducor Petrochemicals launches product range for Healthcare & Life Science applications under ISO 13485 certification

Ducor Petrochemicals, a global partner in the development of polypropylene plastics, has developed a product range that is specifically designed for the production of medical devices and other Life Science applications. The DuCare product range is ISO 13485 certified and specifically designed for Healthcare & Life Science applications.

From Ducor Petrochemicals B.V. 15 Sep 2023

New genetic test reveals a person’s predisposition to happiness

Your happiness levels aren't only based on external events. Genome testing can reveal how happy and optimistic you are predisposed to be. A leading testing expert reveals how variations of a key gene, CNR1, may have a significant impact on your level of happiness.

15 Sep 2023

Comparative genomic analysis between systemic juvenile rheumatoid arthritis and type 1 diabetes

Shared genetic markers and immune system involvement in sJRA and T1D.

15 Sep 2023

Novel amino acid mutations suggest local monkeypox transmission in Guangzhou, China

The monkeypox (mpox) virus has caused worldwide transmission since its initial report in England in early May 2022.

15 Sep 2023

Unlocking the power of lectins: BOA emerges as a potent weapon against all SARS-CoV-2 variants

Researchers discover that antiviral lectins like BOA can effectively inhibit SARS-CoV-2 and its variants by targeting spike glycans, opening doors for potential pan-coronavirus treatments. The study reveals that BOA's multivalent interactions make it a potent inhibitor against a range of viral variants, offering promise for future therapeutic strategies.

14 Sep 2023

Genetic sequencing shows promise as first-tier newborn screening test

Newborn screening (NBS) is routinely performed across the world using biochemical testing methods. Recent advancements in genetic sequencing are a potential game-changer for newborn screening, swiftly assessing a comprehensive range of monogenic disorders.

14 Sep 2023

Vocal learning, problem solving, and brain size may have evolved together, study suggests

The European starling boasts a remarkable repertoire. Versatile songbirds that learn warbles, whistles, calls, and songs throughout their lives, starlings rank among the most advanced avian vocal learners.

14 Sep 2023

Life Science News

New CAR T cell therapy approach minimizes severe side effects

New research offers insight about the reason mitochondrial DNA is maternally inherited

Meridian Bioscience announces FDA clearance for innovative Curian® Shiga Toxin Assay

Meridian Bioscience continues expansion of H. pylori diagnostic testing solutions with FDA clearance of premier HpSA flex

Single-cell screening of cerebral organoids to identify developmental defects in autism

MGI partners with National Cancer Centre Singapore to undergo comprehensive genomic profiling of Asian-Prevalent cancers

MGI and Bio-Medical Science sign MOU to deliver cutting-edge sequencing platforms and reagents to South Korea

MGI's innovative technologies Is enabling sequencing of first plant species in the African BioGenome project

MGI introduces new chapter in smart laboratory management with official opening of αLab in HKSTP

Turning fish waste into cancer fighters: How abalone viscera peptides could be the next big thing in medicine

How well do current vaccines hold up against new SARS-CoV-2 variants BA.2.86 and FLip?

BU researchers receive NIH grant to identify genetic factors for Alzheimer's disease

NICER: A safer alternative to CRISPR/Cas9 for gene editing

Ducor Petrochemicals launches product range for Healthcare & Life Science applications under ISO 13485 certification

New genetic test reveals a person’s predisposition to happiness

Comparative genomic analysis between systemic juvenile rheumatoid arthritis and type 1 diabetes

Novel amino acid mutations suggest local monkeypox transmission in Guangzhou, China

Unlocking the power of lectins: BOA emerges as a potent weapon against all SARS-CoV-2 variants

Genetic sequencing shows promise as first-tier newborn screening test

Vocal learning, problem solving, and brain size may have evolved together, study suggests

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest Life Science News